Lexicon Pharmaceuticals LXRX Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's convertible preferred stock authorized shares?
- Lexicon Pharmaceuticals (LXRX) reported convertible preferred stock authorized shares of 5B in Q1 2026.
- How has Lexicon Pharmaceuticals's convertible preferred stock authorized shares changed year-over-year?
- Lexicon Pharmaceuticals's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 5B to 5B.
- What is the long-term trend for Lexicon Pharmaceuticals's convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's convertible preferred stock authorized shares has grown at a 298.1% compound annual growth rate (CAGR), from 5M to 5B.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.